Search

Author/Creator Prockop, S.

1. CORRELATION OF CIRCULATING EPSTEIN‐BARR VIRUS‐TARGETED CYTOTOXIC T LYMPHOCYTE PRECURSORS (EBV‐CTLp) AND CLINICAL RESPONSE FOLLOWING TABELECLEUCEL (TAB‐CEL) INFUSION IN PATIENTS WITH EBV‐DRIVEN DISEASE. (12th June 2019)

Authors:
Aftab, B.; Munson, D.; Rasor, K.; Foubert, P.; Tsai, D.; Kai Weng, W.; Ghobadi, A.; van Besien, K.; Sun, Y.; Hiremath, M.; Navarrow, W.; Prockop, S.
Journal:
Hematological oncology
Issue:
Volume 37(2019)Supplement 2
Page Start:
503
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE). (23rd June 2022)

Authors:
Prockop, S.; Beitinjaneh, A.; Choquet, S.; Dahiya, S.; Dinavahi, R.; Farah, R.; Gamelin, L.; Ghobadi, A.; Mehta, A.; Nayak, P.; Reshef, R.; Satyanarayana, G.; Stiff, P.; Ye, W.; Mahadeo, K. M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
157
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search